What is PCP
Pre-Commercial Procurement (hereafter PCP) essentially refers to the purchase of research and development (R&D) services by the public sector. It is triggered by procurers identifying the need to solve a socio-economic problem or challenge of public interest for which there is no solution available on the market yet. Accordingly, PCP is not concerned with the procurement of existing products or services on the market but with the R&D phase, which involves solution exploration and design, prototyping, up to the original development of a limited volume of first products or services.
The PCP instrument enables the commissioning of R&D services, under a staged competitive process, to allow the development of innovative solutions that meet the needs of a Contracting Authority. This approach is based on:
1. Risk-benefit sharing according to market conditions;
2. Competitive development in phases;
3. Separation of the R&D phase from deployment of commercial volumes of end-products.
More information: PCP Manual from Inspire project
TicSalut (Spain), NHS24 (UK, in partnership with NHS greater Glasgow and Clyde) and Region South Denmark (Denmark) are partners in the European project Unwired Health aimed at generating a new mHealth system for Heart Failure (HF) management. Considering the needs of both clinicians and patients, looking for the most convenient tools to improve the monitoring of HF (heart Failure) patients. Considering the needs of both clinicians and patients, looking for the most convenient tools to improve the monitoring of HF patients.
The UNWIRED HEALTH PCP application will develop mobile eHealth services to empower heart failure patients accessing their data everywhere, enabling patient-centric care and motivating patients to assume responsibility for their health. This will be also useful to improve patient safety and chronic disease management, through advanced mobile medical applications that process patient-specific information for medical decisions. New approaches in health service will be explored, including care pathways, organisational models and business models in order to provide a robust, scalable platform which allows patients and clinicians the capability to interact.
PCP acts as an effective Catalyst process to the European industry by funding research projects since the procuring authorities will serve as a catalyst, coordinator and technical resource for the benefit of end-users. The Procuring Authorities will award a plurality of bidders to promote collaborative R& D to solve specific needs of the procuring organisations, and consequently testing the validity of alternative prototypes in accordance with predefined requirements and quality standards. The UNWIRED Health covers the process up to Phase 3, after the participating procurers will be responsible for the commercial procurement actions.
Pre-commercial procurement programme with indicated investments by the UNWIRED Health PCP project in each phase.